{"ticker": {"uuid": "671a5839-8f9a-4bbb-93ae-2f45d9a5a1ee", "symbol": "NRSN", "name": "Neurosense Therapeutics Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "NRSN Q2 2026 Earnings: Narrower-Than-Expected Loss Lifts Shares 7.14% - Positive Surprise Momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPUUZ1RW9HQ3ZsSFl3N0kwTUFYMU5iRzJacExldnp0NG1xOTRubmNONkNEU1R1ZndKUi0yTGJKT1drSzQ3OEpNQVFfeUw2N2VPOHZJUzhmMVU2SGZwc29kN0NSRlR4bTM5NjlFWEctQ2dOdVpsMmVFMmwtVlJUWUZXZlNfQjFNNVJxNkdsX2paUzZmYXZoZzNla3o4WnZTeks4em1QU1JuR0hydw?oc=5", "source_link": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPUUZ1RW9HQ3ZsSFl3N0kwTUFYMU5iRzJacExldnp0NG1xOTRubmNONkNEU1R1ZndKUi0yTGJKT1drSzQ3OEpNQVFfeUw2N2VPOHZJUzhmMVU2SGZwc29kN0NSRlR4bTM5NjlFWEctQ2dOdVpsMmVFMmwtVlJUWUZXZlNfQjFNNVJxNkdsX2paUzZmYXZoZzNla3o4WnZTeks4em1QU1JuR0hydw?oc=5", "source_link_is_lookup": false, "source_name": "https://www.dars.gov.et/", "published_at": "2026-10-05T19:32:45+00:00", "published_display": "05 Oct 2026 19:32", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.035996, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 43.3, "age_days": 6.0, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "NeuroSense Therapeutics Ltd. (NRSN) Stock Price, News, Quote & History", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUkFVX3lxTE1fNjhLMkM3ZmxqWWhCd05hczFieS1aaUZsMXRIYklkZDFKcEdQNGpmM28tZHhVUUg2dzhuZlRLck54R2U3dlRFUHRCcEszc2ZQRXc?oc=5", "source_link": "https://news.google.com/rss/articles/CBMiUkFVX3lxTE1fNjhLMkM3ZmxqWWhCd05hczFieS1aaUZsMXRIYklkZDFKcEdQNGpmM28tZHhVUUg2dzhuZlRLck54R2U3dlRFUHRCcEszc2ZQRXc?oc=5", "source_link_is_lookup": false, "source_name": "Yahoo! Finance Canada", "published_at": "2026-10-03T21:45:07+00:00", "published_display": "03 Oct 2026 21:45", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.003927, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 6.4, "age_days": 7.9, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": false}, {"title": "NeuroSense Provides Update on Nasdaq Listing Compliance", "summary": "NeuroSense Therapeutics announced it has received an extension from Nasdaq to meet the minimum bid price requirement. The company now has until February 18, 2027, to regain compliance, provided it meets an interim compliance requirement by August 22, 2026. NeuroSense plans to address the deficiency through various available options to maintain its Nasdaq listing.", "url": "https://www.moomoo.com/news/post/1000567641/neurosense-provides-update-on-nasdaq-listing-compliance", "source_link": "https://www.moomoo.com/news/post/1000567641/neurosense-provides-update-on-nasdaq-listing-compliance", "source_link_is_lookup": false, "source_name": "Moomoo", "published_at": "2026-10-03T16:30:51", "published_display": "03 Oct 2026 16:30", "source_kind": "publisher", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.003257, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 5.9, "age_days": 8.2, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 4, "topics": ["Als", "Biotech", "Clinical Trials", "Finance", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Neurosense Therapeutics Receives Nasdaq Listing Compliance Notice", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/neurosense-therapeutics-receives-nasdaq-listing-203654975.html", "source_link": "https://finance.yahoo.com/markets/stocks/articles/neurosense-therapeutics-receives-nasdaq-listing-203654975.html", "source_link_is_lookup": false, "source_name": "MT Newswires", "published_at": "2026-10-02T20:36:54+00:00", "published_display": "02 Oct 2026 20:36", "source_kind": "publisher", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.001999, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 4.4, "age_days": 9.0, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "The $1 bid-price hurdle is cleared, but NeuroSense (Nasdaq: NRSN) still faces delisting.", "summary": "NeuroSense Therapeutics Ltd. announced that it has regained compliance with Nasdaq's minimum bid price requirement of $1.00 per share after a 1-for-20 reverse share split. However, the company still faces delisting as it failed to meet the $35 million minimum market value of listed securities (MVLS) requirement by September 29, 2026. NeuroSense intends to appeal this decision by requesting a hearing with the Nasdaq Hearings Panel to seek additional time to regain MVLS compliance.", "url": "https://www.stocktitan.net/sec-filings/NRSN/6-k-neuro-sense-therapeutics-ltd-current-report-foreign-issuer-d91228524c43.html", "source_link": "https://www.stocktitan.net/sec-filings/NRSN/6-k-neuro-sense-therapeutics-ltd-current-report-foreign-issuer-d91228524c43.html", "source_link_is_lookup": false, "source_name": "Stock Titan", "published_at": "2026-10-02T20:28:16", "published_display": "02 Oct 2026 20:28", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": ["Failed To Meet"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.003181, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 4.4, "age_days": 9.0, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "A $35 million Nasdaq market-value rule remains unmet; NeuroSense plans to seek more time.", "summary": "NeuroSense Therapeutics (NRSN) has regained compliance with Nasdaq's minimum bid price requirement but faces delisting for failing to meet the $35 million minimum market value of listed securities requirement by the September 29, 2026 deadline. The company intends to appeal this determination by requesting a hearing with the Nasdaq Hearings Panel and seeking additional time to regain compliance. During the appeal process, NeuroSense's shares and warrants are expected to continue trading.", "url": "https://www.stocktitan.net/news/NRSN/neuro-sense-provides-update-on-nasdaq-listing-jv33ygyny5ye.html", "source_link": "https://www.stocktitan.net/news/NRSN/neuro-sense-provides-update-on-nasdaq-listing-jv33ygyny5ye.html", "source_link_is_lookup": false, "source_name": "Stock Titan", "published_at": "2026-10-02T04:15:00", "published_display": "02 Oct 2026 04:15", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.002516, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 3.5, "age_days": 9.7, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Life Sciences", "Financial Markets"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "NeuroSense Therapeutics (Nasdaq:NRSN) - Stock Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxQSXhfY2RGV0pBYXEzRzNoM1F4UkVsMnhDeTBfWmRYcFBDVm8xOHVXRGVfa3ZRSzNzQk51LWZ4OFN6SU4tRmNMM3M2aVU5SjREWGFSbGVpOFVONlRvX2JzelB6djRDTkNEUS05by1aNlVoczlxNXh0Y3R4VmJrSDJTeGQzQzVla2ZzVC1ydEN6WDNSV3BZWGc?oc=5", "source_link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxQSXhfY2RGV0pBYXEzRzNoM1F4UkVsMnhDeTBfWmRYcFBDVm8xOHVXRGVfa3ZRSzNzQk51LWZ4OFN6SU4tRmNMM3M2aVU5SjREWGFSbGVpOFVONlRvX2JzelB6djRDTkNEUS05by1aNlVoczlxNXh0Y3R4VmJrSDJTeGQzQzVla2ZzVC1ydEN6WDNSV3BZWGc?oc=5", "source_link_is_lookup": false, "source_name": "Simply Wall Street", "published_at": "2026-09-30T07:00:00+00:00", "published_display": "30 Sep 2026 07:00", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.001122, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 1.8, "age_days": 11.6, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": false}, {"title": "NeuroSense to Participate in the 5th Annual ROTH Healthcare Opportunities Conference", "summary": "NeuroSense Therapeutics Ltd. announced that its CFO, Or Eisenberg, will participate in the 5th Annual ROTH Healthcare Opportunities Conference on September 29, 2026, in New York City. He will engage in one-on-one and small-group investor meetings to discuss the company's clinical and regulatory progress with PrimeC, their lead drug candidate for ALS, and its strategy for regulatory approval. NeuroSense is a late-stage clinical biotechnology company developing treatments for neurodegenerative diseases, with PrimeC having shown promising results in slowing functional decline in ALS.", "url": "https://www.prnewswire.com/news-releases/neurosense-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference-302891719.html", "source_link": "https://www.prnewswire.com/news-releases/neurosense-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference-302891719.html", "source_link_is_lookup": false, "source_name": "PR Newswire", "published_at": "2026-09-29T16:35:08", "published_display": "29 Sep 2026 16:35", "source_kind": "press_release", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": ["Negative financial language"], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.025729, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 18.5, "age_days": 12.2, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 2, "topics": ["Finance", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "NeuroSense Therapeutics Ltd. (NRSN) Stock Price, News, Quote & History", "summary": "This article provides a detailed overview of NeuroSense Therapeutics Ltd. (NRSN), a clinical-stage biotechnology company focused on neurodegenerative diseases. It covers the company's stock performance, key financial metrics, product pipeline including PrimeC for ALS and Alzheimer's, and recent analyst ratings. The stock experienced significant gains over the past year but showed a slight drop in pre-market trading.", "url": "https://ca.finance.yahoo.com/quote/NRSN", "source_link": "https://ca.finance.yahoo.com/quote/NRSN", "source_link_is_lookup": false, "source_name": "Yahoo! Finance Canada", "published_at": "2026-09-29T08:32:32", "published_display": "29 Sep 2026 08:32", "source_kind": "publisher", "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": ["Positive financial language"], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.00378, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 5.6, "age_days": 12.5, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "NeuroSense CFO will meet investors one-on-one in New York", "summary": "NeuroSense Therapeutics' CFO, Or Eisenberg, will participate in the 5th Annual ROTH Healthcare Opportunities Conference on September 29, 2026, meeting with institutional investors in New York City. Discussions will focus on the clinical and regulatory progress of PrimeC, their ALS drug candidate, and the company's strategy for regulatory approval in Canada, the U.S., and other markets. This news followed a 26.62% drop in NRSN's stock price the previous day.", "url": "https://www.stocktitan.net/news/NRSN/neuro-sense-to-participate-in-the-5th-annual-roth-healthcare-2rrh862r668i.html", "source_link": "https://www.stocktitan.net/news/NRSN/neuro-sense-to-participate-in-the-5th-annual-roth-healthcare-2rrh862r668i.html", "source_link_is_lookup": false, "source_name": "Stock Titan", "published_at": "2026-09-28T18:58:40", "published_display": "28 Sep 2026 18:58", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": ["Regulatory Approval"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000778, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 1.1, "age_days": 13.1, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Finance", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "NeuroSense Provides Business Update and Progress for the First Half of 2026", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/neurosense-provides-business-progress-first-203000192.html", "source_link": "https://finance.yahoo.com/healthcare/articles/neurosense-provides-business-progress-first-203000192.html", "source_link_is_lookup": false, "source_name": "PR Newswire", "published_at": "2026-09-25T20:30:00+00:00", "published_display": "25 Sep 2026 20:30", "source_kind": "press_release", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000273, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.4, "age_days": 16.0, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Without delays, cash won't fund 12 months under NeuroSense's (NASDAQ: NRSN) original development plan.", "summary": "NeuroSense Therapeutics Ltd. reported a net loss of $3.563 million for the first half of 2026 and holds only $231,000 in cash, prompting a \"substantial doubt\" warning about its ability to continue as a going concern. The company's cash resources are insufficient to fund 12 months of operations under its original development plan without delays. NeuroSense is pursuing additional financing and strategic alternatives while advancing its lead drug candidate, PrimeC, towards a New Drug Submission in Canada and an optimized Phase 3 trial in the U.S.", "url": "https://www.stocktitan.net/sec-filings/NRSN/6-k-neuro-sense-therapeutics-ltd-current-report-foreign-issuer-8ee3ee04a651.html", "source_link": "https://www.stocktitan.net/sec-filings/NRSN/6-k-neuro-sense-therapeutics-ltd-current-report-foreign-issuer-8ee3ee04a651.html", "source_link_is_lookup": false, "source_name": "Stock Titan", "published_at": "2026-09-25T20:23:09", "published_display": "25 Sep 2026 20:23", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "negative", "sentiment_pct": 37, "tone_signals": ["Balance-sheet distress"], "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.050634, "evidence_share": 82.8, "evidence_share_display": "82.8", "freshness_pct": 20.5, "age_days": 16.0, "influence_label": "Medium", "evidence_strength": 46, "duplicate_count": 2, "topics": ["Earnings", "Finance", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": true}, {"title": "NRSN Q2 2025 Earnings: Narrower-Than-Expected Loss Offers Little Solace as Shares Slide - Quarterly Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_wFBVV95cUxOclN1TGV1dDhCWFRob2JYLUxMc3g5cktUc25EV29CREs1c1BMMDYzOWVwV0Q4YnhUbTZXbXJ1aTlFejZKcjJ6alA1R2JLYndDV05mMDRUQzhVUS05QV8xZnJGXzl3QWUyREQ5VEVJaEw1US1hcVA3Zy0yTGliZ2hNOFVRY0VwUmtYRXZxT2ctQkZ4Skh5d2VMdXptYUlPUExwV0J4WFd0Z2xaWGJlUzJjT0RFWnJZeWVwZzd2WVVWYnVJb3hWSFZSQ1FTZ2RWc3AtQ1RJbmxrd0xhSlZBaFRpOFdjdUczNkhnTzRyRlVlcWh6aE4waTFwN0F5VmZRSHc?oc=5", "source_link": "https://news.google.com/rss/articles/CBMi_wFBVV95cUxOclN1TGV1dDhCWFRob2JYLUxMc3g5cktUc25EV29CREs1c1BMMDYzOWVwV0Q4YnhUbTZXbXJ1aTlFejZKcjJ6alA1R2JLYndDV05mMDRUQzhVUS05QV8xZnJGXzl3QWUyREQ5VEVJaEw1US1hcVA3Zy0yTGliZ2hNOFVRY0VwUmtYRXZxT2ctQkZ4Skh5d2VMdXptYUlPUExwV0J4WFd0Z2xaWGJlUzJjT0RFWnJZeWVwZzd2WVVWYnVJb3hWSFZSQ1FTZ2RWc3AtQ1RJbmxrd0xhSlZBaFRpOFdjdUczNkhnTzRyRlVlcWh6aE4waTFwN0F5VmZRSHc?oc=5", "source_link_is_lookup": false, "source_name": "dars.gov.et", "published_at": "2026-09-20T12:45:42+00:00", "published_display": "20 Sep 2026 12:45", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "negative", "sentiment_pct": 32, "tone_signals": ["Negative market reaction"], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.010504, "evidence_share": 17.2, "evidence_share_display": "17.2", "freshness_pct": 5.2, "age_days": 21.3, "influence_label": "Medium", "evidence_strength": 47, "duplicate_count": 1, "topics": [], "evidence_basis": "", "score_included": true, "direction_included": true}, {"title": "NeuroSense to Present at H.C. Wainwright 28th Annual Global Investment Conference", "summary": "NeuroSense Therapeutics will present at the H.C. Wainwright 28th Annual Global Investment Conference from September 14-16, 2026, in New York City. The company will discuss its clinical and regulatory progress with PrimeC, its lead drug candidate for ALS, including preparations for the Phase 3 PARAGON trial. NeuroSense management will also be available for one-on-one investor meetings during the conference.", "url": "https://www.prnewswire.com/news-releases/neurosense-to-present-at-hc-wainwright-28th-annual-global-investment-conference-302875258.html", "source_link": "https://www.prnewswire.com/news-releases/neurosense-to-present-at-hc-wainwright-28th-annual-global-investment-conference-302875258.html", "source_link_is_lookup": false, "source_name": "PR Newswire", "published_at": "2026-09-14T01:29:39", "published_display": "14 Sep 2026 01:29", "source_kind": "press_release", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 5e-06, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.0, "age_days": 27.8, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 2, "topics": ["Earnings", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}], "by_tier": {"direct": [{"title": "NRSN Q2 2026 Earnings: Narrower-Than-Expected Loss Lifts Shares 7.14% - Positive Surprise Momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPUUZ1RW9HQ3ZsSFl3N0kwTUFYMU5iRzJacExldnp0NG1xOTRubmNONkNEU1R1ZndKUi0yTGJKT1drSzQ3OEpNQVFfeUw2N2VPOHZJUzhmMVU2SGZwc29kN0NSRlR4bTM5NjlFWEctQ2dOdVpsMmVFMmwtVlJUWUZXZlNfQjFNNVJxNkdsX2paUzZmYXZoZzNla3o4WnZTeks4em1QU1JuR0hydw?oc=5", "source_link": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPUUZ1RW9HQ3ZsSFl3N0kwTUFYMU5iRzJacExldnp0NG1xOTRubmNONkNEU1R1ZndKUi0yTGJKT1drSzQ3OEpNQVFfeUw2N2VPOHZJUzhmMVU2SGZwc29kN0NSRlR4bTM5NjlFWEctQ2dOdVpsMmVFMmwtVlJUWUZXZlNfQjFNNVJxNkdsX2paUzZmYXZoZzNla3o4WnZTeks4em1QU1JuR0hydw?oc=5", "source_link_is_lookup": false, "source_name": "https://www.dars.gov.et/", "published_at": "2026-10-05T19:32:45+00:00", "published_display": "05 Oct 2026 19:32", "provider": "google_news", "providers": ["google_news"], "provider_symbol": "", "provider_symbols": [], "target_provider_symbol": "", "cross_listing": false, "source_names": ["https://www.dars.gov.et/"], "source_kind": "publisher", "story_key": "48a71f94dc42925e7d44fdf8a5cecf69a5f4576fe22f5ac0f35588e4f900cc49", "target_scope": "NRSN Q2 2026 Earnings: Narrower-Than-Expected Loss Lifts Shares 7.14% - Positive Surprise Momentum", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.423, "provider_directional_mass": null, "relevance_score": 0.72, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": false, "sentiment_conflict": 0.65, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.035996, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 43.3, "age_days": 6.0, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "NeuroSense Therapeutics Ltd. (NRSN) Stock Price, News, Quote & History", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUkFVX3lxTE1fNjhLMkM3ZmxqWWhCd05hczFieS1aaUZsMXRIYklkZDFKcEdQNGpmM28tZHhVUUg2dzhuZlRLck54R2U3dlRFUHRCcEszc2ZQRXc?oc=5", "source_link": "https://news.google.com/rss/articles/CBMiUkFVX3lxTE1fNjhLMkM3ZmxqWWhCd05hczFieS1aaUZsMXRIYklkZDFKcEdQNGpmM28tZHhVUUg2dzhuZlRLck54R2U3dlRFUHRCcEszc2ZQRXc?oc=5", "source_link_is_lookup": false, "source_name": "Yahoo! Finance Canada", "published_at": "2026-10-03T21:45:07+00:00", "published_display": "03 Oct 2026 21:45", "provider": "archive", "providers": ["archive", "google_news"], "provider_symbol": "", "provider_symbols": ["NRSN.ARCHIVE"], "target_provider_symbol": "NRSN.ARCHIVE", "cross_listing": false, "source_names": ["Yahoo! Finance Canada"], "source_kind": "publisher", "story_key": "98d44c190c1bff4e48af1b4a6b6fea9c4cbbec418a15ba48090e9d68105420e3", "target_scope": "NeuroSense Therapeutics Ltd. (NRSN) Stock Price, News, Quote & History", "durable_archive": true, "archive_provider": "google_news", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.003927, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 6.4, "age_days": 7.9, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": false}, {"title": "NeuroSense Provides Update on Nasdaq Listing Compliance", "summary": "NeuroSense Therapeutics announced it has received an extension from Nasdaq to meet the minimum bid price requirement. The company now has until February 18, 2027, to regain compliance, provided it meets an interim compliance requirement by August 22, 2026. NeuroSense plans to address the deficiency through various available options to maintain its Nasdaq listing.", "url": "https://www.moomoo.com/news/post/1000567641/neurosense-provides-update-on-nasdaq-listing-compliance", "source_link": "https://www.moomoo.com/news/post/1000567641/neurosense-provides-update-on-nasdaq-listing-compliance", "source_link_is_lookup": false, "source_name": "Moomoo", "published_at": "2026-10-03T16:30:51", "published_display": "03 Oct 2026 16:30", "provider": "alphavantage", "providers": ["alphavantage", "archive", "eodhd", "yfinance"], "provider_symbol": "NRSN.US", "provider_symbols": ["IXIC.INDX", "NRSN", "NRSN.ARCHIVE", "NRSN.US", "^IXIC"], "target_provider_symbol": "NRSN", "cross_listing": false, "source_names": ["Moomoo", "PR Newswire", "finance.yahoo.com"], "source_kind": "publisher", "story_key": "94d329ffc363898ed60fd7ff59ef5eb4cfb7e3c2a0ce9fd8b1cc59c61cbbce4f", "target_scope": "NeuroSense Provides Update on Nasdaq Listing Compliance NeuroSense Therapeutics announced it has received an extension from Nasdaq to meet the minimum bid price requirement. but The company now has until February 18, 2027, to regain compliance, provided it meets an interim compliance requirement by August 22, 2026. NeuroSense plans to address the deficiency through various available options to maintain its Nasdaq listing.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": 0.2251, "relevance_score": 1.0, "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.003257, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 5.9, "age_days": 8.2, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 4, "topics": ["Als", "Biotech", "Clinical Trials", "Finance", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Neurosense Therapeutics Receives Nasdaq Listing Compliance Notice", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/neurosense-therapeutics-receives-nasdaq-listing-203654975.html", "source_link": "https://finance.yahoo.com/markets/stocks/articles/neurosense-therapeutics-receives-nasdaq-listing-203654975.html", "source_link_is_lookup": false, "source_name": "MT Newswires", "published_at": "2026-10-02T20:36:54+00:00", "published_display": "02 Oct 2026 20:36", "provider": "yfinance", "providers": ["yfinance"], "provider_symbol": "", "provider_symbols": ["NRSN", "^IXIC"], "target_provider_symbol": "NRSN", "cross_listing": false, "source_names": ["MT Newswires"], "source_kind": "publisher", "story_key": "5fa2cdc727197240cfe4494f49a2679408460e04f06304228b53231e96cbf365", "target_scope": "Neurosense Therapeutics Receives Nasdaq Listing Compliance Notice", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": null, "relevance_score": 0.72, "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.001999, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 4.4, "age_days": 9.0, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "The $1 bid-price hurdle is cleared, but NeuroSense (Nasdaq: NRSN) still faces delisting.", "summary": "NeuroSense Therapeutics Ltd. announced that it has regained compliance with Nasdaq's minimum bid price requirement of $1.00 per share after a 1-for-20 reverse share split. However, the company still faces delisting as it failed to meet the $35 million minimum market value of listed securities (MVLS) requirement by September 29, 2026. NeuroSense intends to appeal this decision by requesting a hearing with the Nasdaq Hearings Panel to seek additional time to regain MVLS compliance.", "url": "https://www.stocktitan.net/sec-filings/NRSN/6-k-neuro-sense-therapeutics-ltd-current-report-foreign-issuer-d91228524c43.html", "source_link": "https://www.stocktitan.net/sec-filings/NRSN/6-k-neuro-sense-therapeutics-ltd-current-report-foreign-issuer-d91228524c43.html", "source_link_is_lookup": false, "source_name": "Stock Titan", "published_at": "2026-10-02T20:28:16", "published_display": "02 Oct 2026 20:28", "provider": "alphavantage", "providers": ["alphavantage", "archive", "google_news"], "provider_symbol": "", "provider_symbols": ["NRSN", "NRSN.ARCHIVE"], "target_provider_symbol": "NRSN", "cross_listing": false, "source_names": ["Stock Titan"], "source_kind": "publisher", "story_key": "b3849bc1ca7db00ea62452f08f5a22812008c182c970915644eed4bae4b30ad1", "target_scope": "NeuroSense (Nasdaq: NRSN) still faces delisting. NeuroSense Therapeutics Ltd. announced that it has regained compliance with Nasdaq's minimum bid price requirement of $1.00 per share after a 1-for-20 reverse share split. NeuroSense intends to appeal this decision by requesting a hearing with the Nasdaq Hearings Panel to seek additional time to regain MVLS compliance.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": 0.2191, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.003181, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 4.4, "age_days": 9.0, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "A $35 million Nasdaq market-value rule remains unmet; NeuroSense plans to seek more time.", "summary": "NeuroSense Therapeutics (NRSN) has regained compliance with Nasdaq's minimum bid price requirement but faces delisting for failing to meet the $35 million minimum market value of listed securities requirement by the September 29, 2026 deadline. The company intends to appeal this determination by requesting a hearing with the Nasdaq Hearings Panel and seeking additional time to regain compliance. During the appeal process, NeuroSense's shares and warrants are expected to continue trading.", "url": "https://www.stocktitan.net/news/NRSN/neuro-sense-provides-update-on-nasdaq-listing-jv33ygyny5ye.html", "source_link": "https://www.stocktitan.net/news/NRSN/neuro-sense-provides-update-on-nasdaq-listing-jv33ygyny5ye.html", "source_link_is_lookup": false, "source_name": "Stock Titan", "published_at": "2026-10-02T04:15:00", "published_display": "02 Oct 2026 04:15", "provider": "alphavantage", "providers": ["alphavantage"], "provider_symbol": "", "provider_symbols": ["NRSN"], "target_provider_symbol": "NRSN", "cross_listing": false, "source_names": ["Stock Titan"], "source_kind": "publisher", "story_key": "3e232be7eccf8708e3d40a4fc392f499d94468c2edaf68828df33b4d81b27cbb", "target_scope": "NeuroSense plans to seek more time. NeuroSense Therapeutics (NRSN) has regained compliance with Nasdaq's minimum bid price requirement but faces delisting for failing to meet the $35 million minimum market value of listed securities requirement by the September 29, 2026 deadline. but The company intends to appeal this determination by requesting a hearing with the Nasdaq Hearings Panel and seeking additional time to regain compliance. During the appeal process, NeuroSense's shares and warrants are expected to continue trading.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": 0.2056, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.002516, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 3.5, "age_days": 9.7, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Life Sciences", "Financial Markets"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "NeuroSense Therapeutics (Nasdaq:NRSN) - Stock Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxQSXhfY2RGV0pBYXEzRzNoM1F4UkVsMnhDeTBfWmRYcFBDVm8xOHVXRGVfa3ZRSzNzQk51LWZ4OFN6SU4tRmNMM3M2aVU5SjREWGFSbGVpOFVONlRvX2JzelB6djRDTkNEUS05by1aNlVoczlxNXh0Y3R4VmJrSDJTeGQzQzVla2ZzVC1ydEN6WDNSV3BZWGc?oc=5", "source_link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxQSXhfY2RGV0pBYXEzRzNoM1F4UkVsMnhDeTBfWmRYcFBDVm8xOHVXRGVfa3ZRSzNzQk51LWZ4OFN6SU4tRmNMM3M2aVU5SjREWGFSbGVpOFVONlRvX2JzelB6djRDTkNEUS05by1aNlVoczlxNXh0Y3R4VmJrSDJTeGQzQzVla2ZzVC1ydEN6WDNSV3BZWGc?oc=5", "source_link_is_lookup": false, "source_name": "Simply Wall Street", "published_at": "2026-09-30T07:00:00+00:00", "published_display": "30 Sep 2026 07:00", "provider": "archive", "providers": ["archive", "google_news"], "provider_symbol": "", "provider_symbols": ["NRSN.ARCHIVE"], "target_provider_symbol": "NRSN.ARCHIVE", "cross_listing": false, "source_names": ["Simply Wall Street"], "source_kind": "publisher", "story_key": "9f3993ba93c1ebde39d0b048f6859626dfc3bc520f25d51f185785003cc3ddab", "target_scope": "NeuroSense Therapeutics (Nasdaq:NRSN) - Stock Analysis", "durable_archive": true, "archive_provider": "google_news", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.001122, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 1.8, "age_days": 11.6, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "headline_only", "score_included": true, "direction_included": false}, {"title": "NeuroSense to Participate in the 5th Annual ROTH Healthcare Opportunities Conference", "summary": "NeuroSense Therapeutics Ltd. announced that its CFO, Or Eisenberg, will participate in the 5th Annual ROTH Healthcare Opportunities Conference on September 29, 2026, in New York City. He will engage in one-on-one and small-group investor meetings to discuss the company's clinical and regulatory progress with PrimeC, their lead drug candidate for ALS, and its strategy for regulatory approval. NeuroSense is a late-stage clinical biotechnology company developing treatments for neurodegenerative diseases, with PrimeC having shown promising results in slowing functional decline in ALS.", "url": "https://www.prnewswire.com/news-releases/neurosense-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference-302891719.html", "source_link": "https://www.prnewswire.com/news-releases/neurosense-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference-302891719.html", "source_link_is_lookup": false, "source_name": "PR Newswire", "published_at": "2026-09-29T16:35:08", "published_display": "29 Sep 2026 16:35", "provider": "alphavantage", "providers": ["alphavantage", "archive", "yfinance"], "provider_symbol": "", "provider_symbols": ["NRSN", "NRSN.ARCHIVE"], "target_provider_symbol": "NRSN", "cross_listing": false, "source_names": ["PR Newswire"], "source_kind": "press_release", "story_key": "0003e2f9a6bf45f800bc29d3037e6205bb88e07563714999cb2c644d78006e05", "target_scope": "NeuroSense to Participate in the 5th Annual ROTH Healthcare Opportunities Conference NeuroSense Therapeutics Ltd. announced that its CFO, Or Eisenberg, will participate in the 5th Annual ROTH Healthcare Opportunities Conference on September 29, 2026, in New York City. NeuroSense is a late-stage clinical biotechnology company developing treatments for neurodegenerative diseases, with PrimeC having shown promising results in slowing functional decline in ALS.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.51, "provider_directional_mass": 0.3469, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": ["Negative financial language"], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.025729, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 18.5, "age_days": 12.2, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 2, "topics": ["Finance", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "NeuroSense Therapeutics Ltd. (NRSN) Stock Price, News, Quote & History", "summary": "This article provides a detailed overview of NeuroSense Therapeutics Ltd. (NRSN), a clinical-stage biotechnology company focused on neurodegenerative diseases. It covers the company's stock performance, key financial metrics, product pipeline including PrimeC for ALS and Alzheimer's, and recent analyst ratings. The stock experienced significant gains over the past year but showed a slight drop in pre-market trading.", "url": "https://ca.finance.yahoo.com/quote/NRSN", "source_link": "https://ca.finance.yahoo.com/quote/NRSN", "source_link_is_lookup": false, "source_name": "Yahoo! Finance Canada", "published_at": "2026-09-29T08:32:32", "published_display": "29 Sep 2026 08:32", "provider": "alphavantage", "providers": ["alphavantage", "archive", "google_news"], "provider_symbol": "", "provider_symbols": ["AMGN", "BIIB", "MRK", "NRSN", "NRSN.ARCHIVE", "PFE"], "target_provider_symbol": "NRSN", "cross_listing": false, "source_names": ["Yahoo! Finance Canada"], "source_kind": "publisher", "story_key": "98d44c190c1bff4e48af1b4a6b6fea9c4cbbec418a15ba48090e9d68105420e3", "target_scope": "NeuroSense Therapeutics Ltd. (NRSN) Stock Price, News, Quote & History This article provides a detailed overview of NeuroSense Therapeutics Ltd. (NRSN), a clinical-stage biotechnology company focused on neurodegenerative diseases. but It covers the company's stock performance, key financial metrics, product pipeline including PrimeC for ALS and Alzheimer's, and recent analyst ratings.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": 0.1718, "relevance_score": 1.0, "company_focus": 0.78, "company_focus_pct": 78, "company_focus_label": "Shared story", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.00378, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 5.6, "age_days": 12.5, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Earnings", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "NeuroSense CFO will meet investors one-on-one in New York", "summary": "NeuroSense Therapeutics' CFO, Or Eisenberg, will participate in the 5th Annual ROTH Healthcare Opportunities Conference on September 29, 2026, meeting with institutional investors in New York City. Discussions will focus on the clinical and regulatory progress of PrimeC, their ALS drug candidate, and the company's strategy for regulatory approval in Canada, the U.S., and other markets. This news followed a 26.62% drop in NRSN's stock price the previous day.", "url": "https://www.stocktitan.net/news/NRSN/neuro-sense-to-participate-in-the-5th-annual-roth-healthcare-2rrh862r668i.html", "source_link": "https://www.stocktitan.net/news/NRSN/neuro-sense-to-participate-in-the-5th-annual-roth-healthcare-2rrh862r668i.html", "source_link_is_lookup": false, "source_name": "Stock Titan", "published_at": "2026-09-28T18:58:40", "published_display": "28 Sep 2026 18:58", "provider": "alphavantage", "providers": ["alphavantage", "archive"], "provider_symbol": "", "provider_symbols": ["NRSN", "NRSN.ARCHIVE"], "target_provider_symbol": "NRSN", "cross_listing": false, "source_names": ["Stock Titan"], "source_kind": "publisher", "story_key": "29d8a8361931973b9134fb832a1f774ff817f74b1f88f4c0ca509518eb9d8dec", "target_scope": "NeuroSense CFO will meet investors one-on-one in New York NeuroSense Therapeutics' CFO, Or Eisenberg, will participate in the 5th Annual ROTH Healthcare Opportunities Conference on September 29, 2026, meeting with institutional investors in New York City. This news followed a 26.62% drop in NRSN's stock price the previous day.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": 0.124, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000778, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 1.1, "age_days": 13.1, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": ["Finance", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "NeuroSense Provides Business Update and Progress for the First Half of 2026", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/neurosense-provides-business-progress-first-203000192.html", "source_link": "https://finance.yahoo.com/healthcare/articles/neurosense-provides-business-progress-first-203000192.html", "source_link_is_lookup": false, "source_name": "PR Newswire", "published_at": "2026-09-25T20:30:00+00:00", "published_display": "25 Sep 2026 20:30", "provider": "yfinance", "providers": ["archive", "yfinance"], "provider_symbol": "", "provider_symbols": ["NRSN", "NRSN.ARCHIVE"], "target_provider_symbol": "NRSN", "cross_listing": false, "source_names": ["PR Newswire"], "source_kind": "press_release", "story_key": "1ccef985fdfac2d51eac09f4f7cd28e0a4fd78193079d531f5ea61159b8bbd2f", "target_scope": "NeuroSense Provides Business Update and Progress for the First Half of 2026", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000273, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.4, "age_days": 16.0, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "", "score_included": true, "direction_included": false}, {"title": "Without delays, cash won't fund 12 months under NeuroSense's (NASDAQ: NRSN) original development plan.", "summary": "NeuroSense Therapeutics Ltd. reported a net loss of $3.563 million for the first half of 2026 and holds only $231,000 in cash, prompting a \"substantial doubt\" warning about its ability to continue as a going concern. The company's cash resources are insufficient to fund 12 months of operations under its original development plan without delays. NeuroSense is pursuing additional financing and strategic alternatives while advancing its lead drug candidate, PrimeC, towards a New Drug Submission in Canada and an optimized Phase 3 trial in the U.S.", "url": "https://www.stocktitan.net/sec-filings/NRSN/6-k-neuro-sense-therapeutics-ltd-current-report-foreign-issuer-8ee3ee04a651.html", "source_link": "https://www.stocktitan.net/sec-filings/NRSN/6-k-neuro-sense-therapeutics-ltd-current-report-foreign-issuer-8ee3ee04a651.html", "source_link_is_lookup": false, "source_name": "Stock Titan", "published_at": "2026-09-25T20:23:09", "published_display": "25 Sep 2026 20:23", "provider": "alphavantage", "providers": ["alphavantage", "archive", "google_news"], "provider_symbol": "", "provider_symbols": ["NRSN", "NRSN.ARCHIVE"], "target_provider_symbol": "NRSN", "cross_listing": false, "source_names": ["Stock Titan"], "source_kind": "publisher", "story_key": "674b71d9a513984ca2a14895faa288fed7296721086bcccbfb6167ee8db8ac82", "target_scope": "Without delays, cash won't fund 12 months under NeuroSense's (NASDAQ: NRSN) original development plan. NeuroSense Therapeutics Ltd. reported a net loss of $3.563 million for the first half of 2026 and holds only $231,000 in cash, prompting a \"substantial doubt\" warning about its ability to continue as a going concern. but The company's cash resources are insufficient to fund 12 months of operations under its original development plan without delays. NeuroSense is pursuing additional financing and strategic alternatives", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.6419999999999999, "provider_directional_mass": 0.6401, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "negative", "sentiment_pct": 37, "tone_signals": ["Balance-sheet distress"], "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.050634, "evidence_share": 82.8, "evidence_share_display": "82.8", "freshness_pct": 20.5, "age_days": 16.0, "influence_label": "Medium", "evidence_strength": 46, "duplicate_count": 2, "topics": ["Earnings", "Finance", "Financial Markets", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": true}, {"title": "NRSN Q2 2025 Earnings: Narrower-Than-Expected Loss Offers Little Solace as Shares Slide - Quarterly Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_wFBVV95cUxOclN1TGV1dDhCWFRob2JYLUxMc3g5cktUc25EV29CREs1c1BMMDYzOWVwV0Q4YnhUbTZXbXJ1aTlFejZKcjJ6alA1R2JLYndDV05mMDRUQzhVUS05QV8xZnJGXzl3QWUyREQ5VEVJaEw1US1hcVA3Zy0yTGliZ2hNOFVRY0VwUmtYRXZxT2ctQkZ4Skh5d2VMdXptYUlPUExwV0J4WFd0Z2xaWGJlUzJjT0RFWnJZeWVwZzd2WVVWYnVJb3hWSFZSQ1FTZ2RWc3AtQ1RJbmxrd0xhSlZBaFRpOFdjdUczNkhnTzRyRlVlcWh6aE4waTFwN0F5VmZRSHc?oc=5", "source_link": "https://news.google.com/rss/articles/CBMi_wFBVV95cUxOclN1TGV1dDhCWFRob2JYLUxMc3g5cktUc25EV29CREs1c1BMMDYzOWVwV0Q4YnhUbTZXbXJ1aTlFejZKcjJ6alA1R2JLYndDV05mMDRUQzhVUS05QV8xZnJGXzl3QWUyREQ5VEVJaEw1US1hcVA3Zy0yTGliZ2hNOFVRY0VwUmtYRXZxT2ctQkZ4Skh5d2VMdXptYUlPUExwV0J4WFd0Z2xaWGJlUzJjT0RFWnJZeWVwZzd2WVVWYnVJb3hWSFZSQ1FTZ2RWc3AtQ1RJbmxrd0xhSlZBaFRpOFdjdUczNkhnTzRyRlVlcWh6aE4waTFwN0F5VmZRSHc?oc=5", "source_link_is_lookup": false, "source_name": "dars.gov.et", "published_at": "2026-09-20T12:45:42+00:00", "published_display": "20 Sep 2026 12:45", "provider": "google_news", "providers": ["archive", "google_news"], "provider_symbol": "", "provider_symbols": ["NRSN.ARCHIVE"], "target_provider_symbol": "NRSN.ARCHIVE", "cross_listing": false, "source_names": ["careplusvn.com", "dars.gov.et"], "source_kind": "publisher", "story_key": "0b743bb7d6c962f3a55cb0a05de4c657f620c9e6c690b732f117c7337775c4ef", "target_scope": "NRSN Q2 2025 Earnings: Narrower-Than-Expected Loss Offers Little Solace as Shares Slide - Quarterly Earnings", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.6399999999999999, "provider_directional_mass": null, "relevance_score": 0.78, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "negative", "sentiment_pct": 32, "tone_signals": ["Negative market reaction"], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.010504, "evidence_share": 17.2, "evidence_share_display": "17.2", "freshness_pct": 5.2, "age_days": 21.3, "influence_label": "Medium", "evidence_strength": 47, "duplicate_count": 1, "topics": [], "evidence_basis": "", "score_included": true, "direction_included": true}, {"title": "NeuroSense to Present at H.C. Wainwright 28th Annual Global Investment Conference", "summary": "NeuroSense Therapeutics will present at the H.C. Wainwright 28th Annual Global Investment Conference from September 14-16, 2026, in New York City. The company will discuss its clinical and regulatory progress with PrimeC, its lead drug candidate for ALS, including preparations for the Phase 3 PARAGON trial. NeuroSense management will also be available for one-on-one investor meetings during the conference.", "url": "https://www.prnewswire.com/news-releases/neurosense-to-present-at-hc-wainwright-28th-annual-global-investment-conference-302875258.html", "source_link": "https://www.prnewswire.com/news-releases/neurosense-to-present-at-hc-wainwright-28th-annual-global-investment-conference-302875258.html", "source_link_is_lookup": false, "source_name": "PR Newswire", "published_at": "2026-09-14T01:29:39", "published_display": "14 Sep 2026 01:29", "provider": "alphavantage", "providers": ["alphavantage", "archive", "yfinance"], "provider_symbol": "", "provider_symbols": ["NRSN", "NRSN.ARCHIVE"], "target_provider_symbol": "NRSN", "cross_listing": false, "source_names": ["PR Newswire"], "source_kind": "press_release", "story_key": "67532f06b396af7ab6258d61b1eeb4c4d8e63a526303b937cc1246a0461e9eaa", "target_scope": "NeuroSense to Present at H.C. NeuroSense Therapeutics will present at the H.C. NeuroSense management will also be available for one-on-one investor meetings during the conference.", "durable_archive": false, "archive_provider": "", "sentiment_origin": "target_heuristic", "model_confidence": 0.46, "provider_directional_mass": 0.3291, "relevance_score": 1.0, "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 5e-06, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 0.0, "age_days": 27.8, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 2, "topics": ["Earnings", "Life Sciences"], "evidence_basis": "", "score_included": true, "direction_included": false}], "industry": [], "sector": []}, "total_fetched": 16, "total_unique": 16, "total_relevant": 14, "pipeline_health": {"status": "healthy", "providers_attempted": 4, "providers_with_results": 4, "raw_articles": 69, "unique_stories": 43, "duplicates_removed": 26, "relevant_stories": 14, "matched_archive_stories": 35, "current_evidence": 2, "direct_evidence": 14, "archive_articles": 2, "durable_story_count": 16, "durable_evidence_used": true, "durable_collected_at": "2026-10-09T19:53:33.933629+00:00"}, "sentiment_summary": {"positive": 0, "negative": 2, "neutral": 12, "score": 49, "raw_score": 36, "total": 16, "evidence_count": 2, "effective_articles": 1.4, "information_mass": 0.061, "direct_story_count": 14, "directional_story_count": 2, "direct_source_count": 3, "industry_story_count": 0, "sector_story_count": 0, "story_count": 14, "source_count": 3, "source_concentration": 0.7007, "direct_share": 100, "dispersion": 2, "confidence": 19, "evidence_status": "provisional", "score_version": "evidence-v11", "window_days": 30, "weighting_method": "event-aware exponential freshness decay", "newest_article_at": "2026-10-05T19:32:45+00:00", "label": "Early balanced news score", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 83, "events": [{"event": "general", "label": "Market update", "weight": 5.56, "count": 9}, {"event": "earnings", "label": "Earnings", "weight": 1.88, "count": 3}, {"event": "analyst", "label": "Analyst action", "weight": 0.6, "count": 1}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.6, "count": 1}], "positive_events": 0, "negative_events": 2, "pipeline": {"status": "healthy", "providers_attempted": 4, "providers_with_results": 4, "raw_articles": 69, "unique_stories": 43, "duplicates_removed": 26, "relevant_stories": 14, "matched_archive_stories": 35, "current_evidence": 2, "direct_evidence": 14, "archive_articles": 2, "durable_story_count": 16, "durable_evidence_used": true, "durable_collected_at": "2026-10-09T19:53:33.933629+00:00"}}, "market_context": {"has_market_context": true, "latest_close": 3.66, "latest_week": "2026-10-09", "one_week_move": -7.0, "four_week_move": -47.3, "twelve_week_move": -73.2, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.383127, "market_dynamics_buy_signal": false, "relative_strength": -79.712662, "fair_value_gap": -82.5, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 50.431, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-7.0% over one week, -47.3% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Early company-news score", "tone": "neutral", "classification": "provisional", "summary": "Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal.", "confidence": 19, "badges": ["Provisional evidence"], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 4}, {"label": "PR Newswire", "count": 3}, {"label": "Yahoo! Finance Canada", "count": 2}, {"label": "https://www.dars.gov.et/", "count": 1}, {"label": "Moomoo", "count": 1}, {"label": "MT Newswires", "count": 1}, {"label": "Simply Wall Street", "count": 1}, {"label": "dars.gov.et", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 14}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 9}, {"label": "Earnings", "count": 3}, {"label": "Analyst action", "count": 1}, {"label": "Balance sheet", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "49/100", "tone": "neutral", "text": "Early balanced news score"}, {"label": "Evidence confidence", "value": "19/100", "tone": "neutral", "text": "1.4 effective stories after overlap and weighting."}, {"label": "Market reaction", "value": "Early company-news score", "tone": "neutral", "text": "Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "83/100 evidence concentration around this catalyst."}, {"label": "Company focus", "value": "14", "tone": "positive", "text": "100% of weighted evidence is company-specific."}, {"label": "Evidence agreement", "value": "2/100", "tone": "positive", "text": "lower dispersion means the independent stories agree more closely."}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-7.0% over one week, -47.3% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "NRSN Q2 2026 Earnings: Narrower-Than-Expected Loss Lifts Shares 7.14% - Positive Surprise Momentum"}], "updated_at": "2026-10-09T19:53:33.933629+00:00", "detail_intelligence": {"headline": "Early balanced news score", "summary": "14 company-specific stories are available, but there are not yet enough fresh stories from separate publishers for a firm reading.", "status": "provisional", "metrics": [{"label": "News score", "value": 49, "display": "49", "tone": "neutral", "note": "Early balanced news score"}, {"label": "Confidence", "value": 19, "display": "19", "tone": "negative", "note": "thin evidence"}, {"label": "Company news", "value": 100, "display": "100%", "tone": "positive", "note": "14 company stories"}, {"label": "Story agreement", "value": 98, "display": "98", "tone": "positive", "note": "2/100 difference"}], "confidence_drivers": [{"label": "Amount of evidence", "value": 1, "note": "0.061 after freshness weighting"}, {"label": "Source breadth", "value": 60, "note": "3 independent publishers"}, {"label": "Company relevance", "value": 100, "note": "share tied directly to this company"}, {"label": "Freshness", "value": 16, "note": "recency-weighted evidence"}, {"label": "Agreement", "value": 98, "note": "how closely stories agree"}, {"label": "Publisher mix", "value": 30, "note": "less reliance on one publisher"}], "influence": {"events": [{"label": "Balance sheet", "positive": 0.0, "negative": 0.050634, "count": 1, "positive_share": 0.0, "positive_width": 0.0, "negative_share": 82.8, "negative_width": 50.0}, {"label": "Earnings", "positive": 0.0, "negative": 0.010504, "count": 1, "positive_share": 0.0, "positive_width": 0.0, "negative_share": 17.2, "negative_width": 10.372}], "sources": [{"label": "Stock Titan", "weight": 0.050634, "count": 1, "share": 82.8}, {"label": "dars.gov.et", "weight": 0.010504, "count": 1, "share": 17.2}], "directional_count": 2, "retained_count": 14, "source_count": 2, "top_share": 82.8, "axis_max": 82.8}, "freshness": 16, "source_independence": 30, "timeline": [{"date": "2026-09-12", "label": "12 Sep", "count": 0, "score": null, "tone": "neutral", "x": 42.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-13", "label": "13 Sep", "count": 0, "score": null, "tone": "neutral", "x": 73.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-14", "label": "14 Sep", "count": 1, "score": 50, "tone": "neutral", "x": 105.2, "y": 135.0, "volume_height": 17.3, "volume_y": 248.7}, {"date": "2026-09-15", "label": "15 Sep", "count": 0, "score": null, "tone": "neutral", "x": 136.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-16", "label": "16 Sep", "count": 0, "score": null, "tone": "neutral", "x": 168.3, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-17", "label": "17 Sep", "count": 0, "score": null, "tone": "neutral", "x": 199.9, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-18", "label": "18 Sep", "count": 0, "score": null, "tone": "neutral", "x": 231.5, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-19", "label": "19 Sep", "count": 0, "score": null, "tone": "neutral", "x": 263.1, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-20", "label": "20 Sep", "count": 1, "score": 32, "tone": "negative", "x": 294.7, "y": 167.8, "volume_height": 17.3, "volume_y": 248.7}, {"date": "2026-09-21", "label": "21 Sep", "count": 0, "score": null, "tone": "neutral", "x": 326.3, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-22", "label": "22 Sep", "count": 0, "score": null, "tone": "neutral", "x": 357.9, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-23", "label": "23 Sep", "count": 0, "score": null, "tone": "neutral", "x": 389.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-24", "label": "24 Sep", "count": 0, "score": null, "tone": "neutral", "x": 421.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-25", "label": "25 Sep", "count": 2, "score": 37, "tone": "negative", "x": 452.6, "y": 158.7, "volume_height": 34.7, "volume_y": 231.3}, {"date": "2026-09-26", "label": "26 Sep", "count": 0, "score": null, "tone": "neutral", "x": 484.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-27", "label": "27 Sep", "count": 0, "score": null, "tone": "neutral", "x": 515.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-28", "label": "28 Sep", "count": 1, "score": 50, "tone": "neutral", "x": 547.4, "y": 135.0, "volume_height": 17.3, "volume_y": 248.7}, {"date": "2026-09-29", "label": "29 Sep", "count": 2, "score": 50, "tone": "neutral", "x": 579.0, "y": 135.0, "volume_height": 34.7, "volume_y": 231.3}, {"date": "2026-09-30", "label": "30 Sep", "count": 1, "score": 50, "tone": "neutral", "x": 610.6, "y": 135.0, "volume_height": 17.3, "volume_y": 248.7}, {"date": "2026-10-01", "label": "01 Oct", "count": 0, "score": null, "tone": "neutral", "x": 642.1, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-02", "label": "02 Oct", "count": 3, "score": 50, "tone": "neutral", "x": 673.7, "y": 135.0, "volume_height": 52.0, "volume_y": 214.0}, {"date": "2026-10-03", "label": "03 Oct", "count": 2, "score": 50, "tone": "neutral", "x": 705.3, "y": 135.0, "volume_height": 34.7, "volume_y": 231.3}, {"date": "2026-10-04", "label": "04 Oct", "count": 0, "score": null, "tone": "neutral", "x": 736.9, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-05", "label": "05 Oct", "count": 1, "score": 50, "tone": "neutral", "x": 768.5, "y": 135.0, "volume_height": 17.3, "volume_y": 248.7}, {"date": "2026-10-06", "label": "06 Oct", "count": 0, "score": null, "tone": "neutral", "x": 800.1, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-07", "label": "07 Oct", "count": 0, "score": null, "tone": "neutral", "x": 831.7, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-08", "label": "08 Oct", "count": 0, "score": null, "tone": "neutral", "x": 863.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-09", "label": "09 Oct", "count": 0, "score": null, "tone": "neutral", "x": 894.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-10", "label": "10 Oct", "count": 0, "score": null, "tone": "neutral", "x": 926.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-10-11", "label": "11 Oct", "count": 0, "score": null, "tone": "neutral", "x": 958.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}], "timeline_points": "105.2,135.0 294.7,167.8 452.6,158.7 547.4,135.0 579.0,135.0 610.6,135.0 673.7,135.0 705.3,135.0 768.5,135.0", "timeline_path": "M105.2,135.0 M294.7,167.8 M452.6,158.7 M547.4,135.0 L579.0,135.0 L610.6,135.0 M673.7,135.0 L705.3,135.0 M768.5,135.0", "timeline_has_signal": true, "timeline_start": "12 Sep", "timeline_mid": "27 Sep", "timeline_end": "11 Oct", "momentum": {"label": "Cooling", "tone": "neutral", "recent_score": null, "prior_score": null, "delta": null, "recent_count": 0, "prior_count": 0, "volume_delta": 0, "reliable": false, "reliability_note": "Thin comparison; direction is not yet confirmed"}, "early_change": {"label": "No new story in 24 hours", "tone": "neutral", "latest_score": null, "baseline_score": 50, "delta": null, "latest_count": 0, "baseline_count": 1, "confirmed": false, "note": "A comparison needs current and earlier-week company news"}, "freshness_buckets": [{"label": "Last 24 hours", "count": 0, "share": 0}, {"label": "1 to 3 days", "count": 0, "share": 0}, {"label": "4 to 7 days", "count": 1, "share": 7}, {"label": "8 to 14 days", "count": 9, "share": 64}, {"label": "15 to 21 days", "count": 2, "share": 14}, {"label": "22 to 30 days", "count": 2, "share": 14}], "source_profile": [{"label": "Stock Titan", "count": 4, "share": 29, "score": 38, "tone": "negative"}, {"label": "PR Newswire", "count": 3, "share": 21, "score": 50, "tone": "neutral"}, {"label": "Yahoo! Finance Canada", "count": 2, "share": 14, "score": 50, "tone": "neutral"}, {"label": "dars.gov.et", "count": 1, "share": 7, "score": 32, "tone": "negative"}, {"label": "https://www.dars.gov.et/", "count": 1, "share": 7, "score": 50, "tone": "neutral"}, {"label": "Moomoo", "count": 1, "share": 7, "score": 50, "tone": "neutral"}, {"label": "MT Newswires", "count": 1, "share": 7, "score": 50, "tone": "neutral"}], "event_profile": [{"label": "Market update", "count": 9, "share": 64, "score": 50, "tone": "neutral"}, {"label": "Earnings", "count": 3, "share": 21, "score": 47, "tone": "neutral"}, {"label": "Balance sheet", "count": 1, "share": 7, "score": 37, "tone": "negative"}, {"label": "Analyst action", "count": 1, "share": 7, "score": 50, "tone": "neutral"}], "topics": [{"label": "Life Sciences", "count": 8, "share": 57}, {"label": "Financial Markets", "count": 5, "share": 36}, {"label": "Finance", "count": 4, "share": 29}, {"label": "Earnings", "count": 3, "share": 21}, {"label": "Clinical Trials", "count": 1, "share": 7}, {"label": "Biotech", "count": 1, "share": 7}, {"label": "Als", "count": 1, "share": 7}], "supporting": [{"label": "Direct evidence", "text": "14 current stories are mapped specifically to NRSN."}, {"label": "Source breadth", "text": "The score uses 3 publishers rather than depending on one outlet."}], "tempering": [{"label": "Too little evidence", "text": "The stories agree, but freshness-weighted evidence is only 0.061."}, {"label": "Confidence", "text": "Confidence is 19/100, below the threshold for a firm score."}], "supporting_heading": "What supports the score", "tempering_heading": "What limits the score", "latest_observation": {"title": "NRSN Q2 2026 Earnings: Narrower-Than-Expected Loss Lifts Shares 7.14% - Positive Surprise Momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPUUZ1RW9HQ3ZsSFl3N0kwTUFYMU5iRzJacExldnp0NG1xOTRubmNONkNEU1R1ZndKUi0yTGJKT1drSzQ3OEpNQVFfeUw2N2VPOHZJUzhmMVU2SGZwc29kN0NSRlR4bTM5NjlFWEctQ2dOdVpsMmVFMmwtVlJUWUZXZlNfQjFNNVJxNkdsX2paUzZmYXZoZzNla3o4WnZTeks4em1QU1JuR0hydw?oc=5", "source_link": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPUUZ1RW9HQ3ZsSFl3N0kwTUFYMU5iRzJacExldnp0NG1xOTRubmNONkNEU1R1ZndKUi0yTGJKT1drSzQ3OEpNQVFfeUw2N2VPOHZJUzhmMVU2SGZwc29kN0NSRlR4bTM5NjlFWEctQ2dOdVpsMmVFMmwtVlJUWUZXZlNfQjFNNVJxNkdsX2paUzZmYXZoZzNla3o4WnZTeks4em1QU1JuR0hydw?oc=5", "source_link_is_lookup": false, "source_name": "https://www.dars.gov.et/", "published_at": "2026-10-05T19:32:45+00:00", "published_display": "05 Oct 2026 19:32", "source_kind": "publisher", "company_focus": 1.0, "company_focus_pct": 100, "company_focus_label": "Main company", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.035996, "evidence_share": 0.0, "evidence_share_display": "0", "freshness_pct": 43.3, "age_days": 6.0, "influence_label": "None", "evidence_strength": 0, "duplicate_count": 1, "topics": [], "evidence_basis": "", "score_included": true, "direction_included": false}, "article_count": 14, "updated_at": "2026-10-09T19:53:33.933629+00:00"}, "price_sentiment_path": {"available": true, "price_points": [{"x": 42.0, "y": 95.2, "label": "17 Apr 2026", "close": 14.14, "index": 100.0}, {"x": 78.4, "y": 86.3, "label": "24 Apr 2026", "close": 15.002, "index": 106.1}, {"x": 114.9, "y": 55.8, "label": "01 May 2026", "close": 17.932, "index": 126.8}, {"x": 151.3, "y": 59.3, "label": "08 May 2026", "close": 17.6, "index": 124.5}, {"x": 187.7, "y": 70.4, "label": "15 May 2026", "close": 16.532, "index": 116.9}, {"x": 224.2, "y": 71.7, "label": "22 May 2026", "close": 16.4, "index": 116.0}, {"x": 260.6, "y": 71.4, "label": "29 May 2026", "close": 16.428, "index": 116.2}, {"x": 297.0, "y": 86.3, "label": "05 Jun 2026", "close": 15.002, "index": 106.1}, {"x": 333.5, "y": 89.4, "label": "12 Jun 2026", "close": 14.704, "index": 104.0}, {"x": 369.9, "y": 74.9, "label": "19 Jun 2026", "close": 16.092, "index": 113.8}, {"x": 406.3, "y": 84.8, "label": "26 Jun 2026", "close": 15.148, "index": 107.1}, {"x": 442.8, "y": 95.0, "label": "03 Jul 2026", "close": 14.16, "index": 100.1}, {"x": 479.2, "y": 90.8, "label": "10 Jul 2026", "close": 14.57, "index": 103.0}, {"x": 515.6, "y": 100.0, "label": "17 Jul 2026", "close": 13.68, "index": 96.7}, {"x": 552.0, "y": 117.0, "label": "24 Jul 2026", "close": 12.042, "index": 85.2}, {"x": 588.5, "y": 145.5, "label": "31 Jul 2026", "close": 9.304, "index": 65.8}, {"x": 624.9, "y": 138.3, "label": "07 Aug 2026", "close": 9.998, "index": 70.7}, {"x": 661.3, "y": 148.0, "label": "14 Aug 2026", "close": 9.062, "index": 64.1}, {"x": 697.8, "y": 164.0, "label": "21 Aug 2026", "close": 7.526, "index": 53.2}, {"x": 734.2, "y": 154.8, "label": "28 Aug 2026", "close": 8.408, "index": 59.5}, {"x": 770.6, "y": 136.0, "label": "04 Sep 2026", "close": 10.216, "index": 72.2}, {"x": 807.1, "y": 170.0, "label": "11 Sep 2026", "close": 6.944, "index": 49.1}, {"x": 843.5, "y": 176.2, "label": "18 Sep 2026", "close": 6.35, "index": 44.9}, {"x": 879.9, "y": 170.0, "label": "25 Sep 2026", "close": 6.95, "index": 49.2}, {"x": 916.4, "y": 201.3, "label": "02 Oct 2026", "close": 3.935, "index": 27.8}, {"x": 952.8, "y": 204.2, "label": "09 Oct 2026", "close": 3.66, "index": 25.9}], "sentiment_points": [{"at": "2026-06-26T23:59:59.999Z", "date": "2026-06-26", "label": "26 Jun 2026", "score": 50, "tone": "neutral", "raw_score": 50, "confidence": 0, "stories": 5, "close": 15.148, "price_change": -5.9, "x": 411.5, "y": 130.0, "show_label": true, "label_y": 120.0}, {"at": "2026-07-03T23:59:59.999Z", "date": "2026-07-03", "label": "03 Jul 2026", "score": 50, "tone": "neutral", "raw_score": 50, "confidence": 0, "stories": 8, "close": 14.16, "price_change": -6.5, "x": 448.0, "y": 130.0, "show_label": false, "label_y": 120.0}, {"at": "2026-07-10T23:59:59.999Z", "date": "2026-07-10", "label": "10 Jul 2026", "score": 50, "tone": "neutral", "raw_score": 50, "confidence": 0, "stories": 10, "close": 14.57, "price_change": 2.9, "x": 484.4, "y": 130.0, "show_label": false, "label_y": 120.0}, {"at": "2026-07-17T23:59:59.999Z", "date": "2026-07-17", "label": "17 Jul 2026", "score": 50, "tone": "neutral", "raw_score": 50, "confidence": 0, "stories": 12, "close": 13.68, "price_change": -6.1, "x": 520.8, "y": 130.0, "show_label": true, "label_y": 120.0}, {"at": "2026-07-24T23:59:59.999Z", "date": "2026-07-24", "label": "24 Jul 2026", "score": 48, "tone": "neutral", "raw_score": 37, "confidence": 29, "stories": 16, "close": 12.042, "price_change": -12.0, "x": 557.2, "y": 133.7, "show_label": false, "label_y": 123.69999999999999}, {"at": "2026-07-31T23:59:59.999Z", "date": "2026-07-31", "label": "31 Jul 2026", "score": 47, "tone": "neutral", "raw_score": 36, "confidence": 29, "stories": 19, "close": 9.304, "price_change": -22.7, "x": 593.7, "y": 135.5, "show_label": false, "label_y": 125.5}, {"at": "2026-08-07T23:59:59.999Z", "date": "2026-08-07", "label": "07 Aug 2026", "score": 49, "tone": "neutral", "raw_score": 46, "confidence": 25, "stories": 23, "close": 9.998, "price_change": 7.5, "x": 630.1, "y": 131.8, "show_label": true, "label_y": 121.80000000000001}, {"at": "2026-08-14T23:59:59.999Z", "date": "2026-08-14", "label": "14 Aug 2026", "score": 51, "tone": "neutral", "raw_score": 57, "confidence": 24, "stories": 25, "close": 9.062, "price_change": -9.4, "x": 666.5, "y": 128.2, "show_label": false, "label_y": 118.19999999999999}, {"at": "2026-08-21T23:59:59.999Z", "date": "2026-08-21", "label": "21 Aug 2026", "score": 50, "tone": "neutral", "raw_score": 51, "confidence": 21, "stories": 22, "close": 7.526, "price_change": -16.9, "x": 703.0, "y": 130.0, "show_label": false, "label_y": 120.0}, {"at": "2026-08-28T23:59:59.999Z", "date": "2026-08-28", "label": "28 Aug 2026", "score": 50, "tone": "neutral", "raw_score": 52, "confidence": 17, "stories": 14, "close": 8.408, "price_change": 11.7, "x": 739.4, "y": 130.0, "show_label": true, "label_y": 120.0}, {"at": "2026-09-04T23:59:59.999Z", "date": "2026-09-04", "label": "04 Sep 2026", "score": 52, "tone": "neutral", "raw_score": 58, "confidence": 32, "stories": 14, "close": 10.216, "price_change": 21.5, "x": 775.8, "y": 126.3, "show_label": false, "label_y": 116.3}, {"at": "2026-09-11T23:59:59.999Z", "date": "2026-09-11", "label": "11 Sep 2026", "score": 51, "tone": "neutral", "raw_score": 55, "confidence": 24, "stories": 11, "close": 6.944, "price_change": -32.0, "x": 812.3, "y": 128.2, "show_label": false, "label_y": 118.19999999999999}, {"at": "2026-09-18T23:59:59.999Z", "date": "2026-09-18", "label": "18 Sep 2026", "score": 51, "tone": "neutral", "raw_score": 57, "confidence": 19, "stories": 9, "close": 6.35, "price_change": -8.6, "x": 848.7, "y": 128.2, "show_label": true, "label_y": 118.19999999999999}, {"at": "2026-09-25T23:59:59.999Z", "date": "2026-09-25", "label": "25 Sep 2026", "score": 47, "tone": "neutral", "raw_score": 38, "confidence": 30, "stories": 11, "close": 6.95, "price_change": 9.4, "x": 885.1, "y": 135.5, "show_label": false, "label_y": 125.5}, {"at": "2026-10-02T23:59:59.999Z", "date": "2026-10-02", "label": "02 Oct 2026", "score": 49, "tone": "neutral", "raw_score": 44, "confidence": 29, "stories": 14, "close": 3.935, "price_change": -43.4, "x": 921.6, "y": 131.8, "show_label": false, "label_y": 121.80000000000001}, {"at": "2026-10-09T23:59:59.999Z", "date": "2026-10-09", "label": "09 Oct 2026", "score": 49, "tone": "neutral", "raw_score": 45, "confidence": 20, "stories": 15, "close": 3.66, "price_change": -7.0, "x": 958.0, "y": 131.8, "show_label": true, "label_y": 121.80000000000001}], "price_path": "42.0,95.2 78.4,86.3 114.9,55.8 151.3,59.3 187.7,70.4 224.2,71.7 260.6,71.4 297.0,86.3 333.5,89.4 369.9,74.9 406.3,84.8 442.8,95.0 479.2,90.8 515.6,100.0 552.0,117.0 588.5,145.5 624.9,138.3 661.3,148.0 697.8,164.0 734.2,154.8 770.6,136.0 807.1,170.0 843.5,176.2 879.9,170.0 916.4,201.3 952.8,204.2", "sentiment_path": "411.5,130.0 448.0,130.0 484.4,130.0 520.8,130.0 557.2,133.7 593.7,135.5 630.1,131.8 666.5,128.2 703.0,130.0 739.4,130.0 775.8,126.3 812.3,128.2 848.7,128.2 885.1,135.5 921.6,131.8 958.0,131.8", "score_version": "evidence-v11", "price_change": -74.1, "sentiment_change": -1, "recent_pairs": [{"at": "2026-10-09T23:59:59.999Z", "date": "2026-10-09", "label": "09 Oct 2026", "score": 49, "tone": "neutral", "raw_score": 45, "confidence": 20, "stories": 15, "close": 3.66, "price_change": -7.0, "x": 958.0, "y": 131.8, "show_label": true, "label_y": 121.80000000000001}, {"at": "2026-10-02T23:59:59.999Z", "date": "2026-10-02", "label": "02 Oct 2026", "score": 49, "tone": "neutral", "raw_score": 44, "confidence": 29, "stories": 14, "close": 3.935, "price_change": -43.4, "x": 921.6, "y": 131.8, "show_label": false, "label_y": 121.80000000000001}, {"at": "2026-09-25T23:59:59.999Z", "date": "2026-09-25", "label": "25 Sep 2026", "score": 47, "tone": "neutral", "raw_score": 38, "confidence": 30, "stories": 11, "close": 6.95, "price_change": 9.4, "x": 885.1, "y": 135.5, "show_label": false, "label_y": 125.5}, {"at": "2026-09-18T23:59:59.999Z", "date": "2026-09-18", "label": "18 Sep 2026", "score": 51, "tone": "neutral", "raw_score": 57, "confidence": 19, "stories": 9, "close": 6.35, "price_change": -8.6, "x": 848.7, "y": 128.2, "show_label": true, "label_y": 118.19999999999999}, {"at": "2026-09-11T23:59:59.999Z", "date": "2026-09-11", "label": "11 Sep 2026", "score": 51, "tone": "neutral", "raw_score": 55, "confidence": 24, "stories": 11, "close": 6.944, "price_change": -32.0, "x": 812.3, "y": 128.2, "show_label": false, "label_y": 118.19999999999999}, {"at": "2026-09-04T23:59:59.999Z", "date": "2026-09-04", "label": "04 Sep 2026", "score": 52, "tone": "neutral", "raw_score": 58, "confidence": 32, "stories": 14, "close": 10.216, "price_change": 21.5, "x": 775.8, "y": 126.3, "show_label": false, "label_y": 116.3}, {"at": "2026-08-28T23:59:59.999Z", "date": "2026-08-28", "label": "28 Aug 2026", "score": 50, "tone": "neutral", "raw_score": 52, "confidence": 17, "stories": 14, "close": 8.408, "price_change": 11.7, "x": 739.4, "y": 130.0, "show_label": true, "label_y": 120.0}, {"at": "2026-08-21T23:59:59.999Z", "date": "2026-08-21", "label": "21 Aug 2026", "score": 50, "tone": "neutral", "raw_score": 51, "confidence": 21, "stories": 22, "close": 7.526, "price_change": -16.9, "x": 703.0, "y": 130.0, "show_label": false, "label_y": 120.0}], "reconstructed": true, "latest_close": 3.66, "price_observations": 26, "sentiment_observations": 16, "sentiment_start_label": "26 Jun 2026", "sentiment_end_label": "09 Oct 2026", "sentiment_history_limited": false, "price_axis_high": 138.9, "price_axis_mid": 76.4, "price_axis_low": 13.8, "start_label": "17 Apr", "mid_label": "14 Jul", "end_label": "09 Oct", "live_score_version": "evidence-v11", "comparable_to_live": true}, "sentiment_history": [{"label": "21 Jun 23:59", "short_label": "21 Jun", "collected_at": "2026-06-21T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": null, "score_change_display": "Start", "confidence_change": null, "article_change": null, "tone": "neutral", "height": 4, "articles": 1, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true}, {"label": "22 Jun 23:59", "short_label": "22 Jun", "collected_at": "2026-06-22T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 2, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true}, {"label": "25 Jun 23:59", "short_label": "25 Jun", "collected_at": "2026-06-25T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 3, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true}, {"label": "26 Jun 23:59", "short_label": "26 Jun", "collected_at": "2026-06-26T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 2, "tone": "neutral", "height": 4, "articles": 5, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true}, {"label": "28 Jun 23:59", "short_label": "28 Jun", "collected_at": "2026-06-28T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 6, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true}, {"label": "29 Jun 23:59", "short_label": "29 Jun", "collected_at": "2026-06-29T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 7, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true}, {"label": "03 Jul 23:59", "short_label": "03 Jul", "collected_at": "2026-07-03T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 8, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true}, {"label": "06 Jul 23:59", "short_label": "06 Jul", "collected_at": "2026-07-06T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 9, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true}, {"label": "10 Jul 23:59", "short_label": "10 Jul", "collected_at": "2026-07-10T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 10, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true}, {"label": "11 Jul 23:59", "short_label": "11 Jul", "collected_at": "2026-07-11T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 11, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true}, {"label": "15 Jul 23:59", "short_label": "15 Jul", "collected_at": "2026-07-15T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 12, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true}, {"label": "22 Jul 23:59", "short_label": "22 Jul", "collected_at": "2026-07-22T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 2, "tone": "neutral", "height": 4, "articles": 14, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true}, {"label": "23 Jul 23:59", "short_label": "23 Jul", "collected_at": "2026-07-23T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 26, "article_change": 1, "tone": "neutral", "height": 4, "articles": 15, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "24 Jul 23:59", "short_label": "24 Jul", "collected_at": "2026-07-24T23:59:59.999999+00:00", "score": 48, "delta": -2, "score_change": -2, "score_change_display": "-2", "confidence_change": 3, "article_change": 1, "tone": "neutral", "height": 4, "articles": 16, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "25 Jul 23:59", "short_label": "25 Jul", "collected_at": "2026-07-25T23:59:59.999999+00:00", "score": 48, "delta": -2, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": 0, "tone": "neutral", "height": 4, "articles": 16, "confidence": 27, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "27 Jul 23:59", "short_label": "27 Jul", "collected_at": "2026-07-27T23:59:59.999999+00:00", "score": 47, "delta": -3, "score_change": -1, "score_change_display": "-1", "confidence_change": 3, "article_change": 0, "tone": "neutral", "height": 6, "articles": 16, "confidence": 30, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "28 Jul 23:59", "short_label": "28 Jul", "collected_at": "2026-07-28T23:59:59.999999+00:00", "score": 47, "delta": -3, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": 2, "tone": "neutral", "height": 6, "articles": 18, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "29 Jul 23:59", "short_label": "29 Jul", "collected_at": "2026-07-29T23:59:59.999999+00:00", "score": 47, "delta": -3, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": 0, "tone": "neutral", "height": 6, "articles": 18, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "30 Jul 23:59", "short_label": "30 Jul", "collected_at": "2026-07-30T23:59:59.999999+00:00", "score": 47, "delta": -3, "score_change": 0, "score_change_display": "+0", "confidence_change": 5, "article_change": 1, "tone": "neutral", "height": 6, "articles": 19, "confidence": 31, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "01 Aug 23:59", "short_label": "01 Aug", "collected_at": "2026-08-01T23:59:59.999999+00:00", "score": 47, "delta": -3, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 2, "tone": "neutral", "height": 6, "articles": 21, "confidence": 31, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "02 Aug 23:59", "short_label": "02 Aug", "collected_at": "2026-08-02T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": 2, "score_change_display": "+2", "confidence_change": 2, "article_change": 0, "tone": "neutral", "height": 4, "articles": 21, "confidence": 33, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "04 Aug 23:59", "short_label": "04 Aug", "collected_at": "2026-08-04T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": 0, "score_change_display": "+0", "confidence_change": -4, "article_change": 1, "tone": "neutral", "height": 4, "articles": 22, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "06 Aug 23:59", "short_label": "06 Aug", "collected_at": "2026-08-06T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": 0, "score_change_display": "+0", "confidence_change": -3, "article_change": 1, "tone": "neutral", "height": 4, "articles": 23, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "08 Aug 23:59", "short_label": "08 Aug", "collected_at": "2026-08-08T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 3, "score_change_display": "+3", "confidence_change": 3, "article_change": 1, "tone": "neutral", "height": 4, "articles": 24, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "10 Aug 23:59", "short_label": "10 Aug", "collected_at": "2026-08-10T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 0, "score_change_display": "+0", "confidence_change": 1, "article_change": 0, "tone": "neutral", "height": 4, "articles": 24, "confidence": 30, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "13 Aug 23:59", "short_label": "13 Aug", "collected_at": "2026-08-13T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 0, "score_change_display": "+0", "confidence_change": -5, "article_change": 2, "tone": "neutral", "height": 4, "articles": 26, "confidence": 25, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "17 Aug 23:59", "short_label": "17 Aug", "collected_at": "2026-08-17T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": -2, "score_change_display": "-2", "confidence_change": 1, "article_change": 0, "tone": "neutral", "height": 4, "articles": 26, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "25 Aug 23:59", "short_label": "25 Aug", "collected_at": "2026-08-25T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": -8, "article_change": -6, "tone": "neutral", "height": 4, "articles": 20, "confidence": 18, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "31 Aug 23:59", "short_label": "31 Aug", "collected_at": "2026-08-31T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": -8, "tone": "neutral", "height": 4, "articles": 12, "confidence": 16, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "01 Sep 23:59", "short_label": "01 Sep", "collected_at": "2026-09-01T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 1, "score_change_display": "+1", "confidence_change": 12, "article_change": 1, "tone": "neutral", "height": 4, "articles": 13, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "02 Sep 23:59", "short_label": "02 Sep", "collected_at": "2026-09-02T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 14, "confidence": 27, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "04 Sep 23:59", "short_label": "04 Sep", "collected_at": "2026-09-04T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 1, "score_change_display": "+1", "confidence_change": 5, "article_change": 0, "tone": "neutral", "height": 4, "articles": 14, "confidence": 32, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "09 Sep 23:59", "short_label": "09 Sep", "collected_at": "2026-09-09T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": -1, "score_change_display": "-1", "confidence_change": -4, "article_change": -4, "tone": "neutral", "height": 4, "articles": 10, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "11 Sep 23:59", "short_label": "11 Sep", "collected_at": "2026-09-11T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": -4, "article_change": 1, "tone": "neutral", "height": 4, "articles": 11, "confidence": 24, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "14 Sep 23:59", "short_label": "14 Sep", "collected_at": "2026-09-14T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": -1, "tone": "neutral", "height": 4, "articles": 10, "confidence": 22, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "20 Sep 23:59", "short_label": "20 Sep", "collected_at": "2026-09-20T23:59:59.999999+00:00", "score": 48, "delta": -2, "score_change": -3, "score_change_display": "-3", "confidence_change": 7, "article_change": 0, "tone": "neutral", "height": 4, "articles": 10, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "25 Sep 23:59", "short_label": "25 Sep", "collected_at": "2026-09-25T23:59:59.999999+00:00", "score": 47, "delta": -3, "score_change": -1, "score_change_display": "-1", "confidence_change": 1, "article_change": 1, "tone": "neutral", "height": 6, "articles": 11, "confidence": 30, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "28 Sep 23:59", "short_label": "28 Sep", "collected_at": "2026-09-28T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": 2, "score_change_display": "+2", "confidence_change": 1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 12, "confidence": 31, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "29 Sep 23:59", "short_label": "29 Sep", "collected_at": "2026-09-29T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": 2, "tone": "neutral", "height": 4, "articles": 14, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "30 Sep 23:59", "short_label": "30 Sep", "collected_at": "2026-09-30T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": 0, "tone": "neutral", "height": 4, "articles": 14, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "02 Oct 23:59", "short_label": "02 Oct", "collected_at": "2026-10-02T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": 0, "score_change_display": "+0", "confidence_change": 1, "article_change": 0, "tone": "neutral", "height": 4, "articles": 14, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "03 Oct 23:59", "short_label": "03 Oct", "collected_at": "2026-10-03T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": 0, "score_change_display": "+0", "confidence_change": -3, "article_change": 2, "tone": "neutral", "height": 4, "articles": 16, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "05 Oct 23:59", "short_label": "05 Oct", "collected_at": "2026-10-05T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": 0, "score_change_display": "+0", "confidence_change": -3, "article_change": 0, "tone": "neutral", "height": 4, "articles": 16, "confidence": 23, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "11 Oct 20:16", "short_label": "11 Oct", "collected_at": "2026-10-11T20:16:07.913981+00:00", "score": 50, "delta": 0, "score_change": 1, "score_change_display": "+1", "confidence_change": -4, "article_change": -2, "tone": "neutral", "height": 4, "articles": 14, "confidence": 19, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}], "sentiment_history_insight": {"available": true, "series_version": "evidence-v11", "live_version": "evidence-v11", "comparable_to_live": true, "reconstructed": true, "observations": 44, "span_label": "112 days", "first_score": 50, "latest_score": 50, "net_change": 0, "net_change_display": "+0", "direction": "Broadly stable", "high_score": 52, "low_score": 47, "latest_confidence": 19, "confidence_change": 19, "latest_articles": 14, "article_change": 13, "latest_label": "11 Oct 20:16", "latest_evidence_label": "Provisional", "chart_rows": [{"label": "21 Jun 23:59", "short_label": "21 Jun", "collected_at": "2026-06-21T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": null, "score_change_display": "Start", "confidence_change": null, "article_change": null, "tone": "neutral", "height": 4, "articles": 1, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true, "x": 42.0, "y": 135.0}, {"label": "22 Jun 23:59", "short_label": "22 Jun", "collected_at": "2026-06-22T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 2, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true, "x": 63.3, "y": 135.0}, {"label": "25 Jun 23:59", "short_label": "25 Jun", "collected_at": "2026-06-25T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 3, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true, "x": 84.6, "y": 135.0}, {"label": "26 Jun 23:59", "short_label": "26 Jun", "collected_at": "2026-06-26T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 2, "tone": "neutral", "height": 4, "articles": 5, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true, "x": 105.9, "y": 135.0}, {"label": "28 Jun 23:59", "short_label": "28 Jun", "collected_at": "2026-06-28T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 6, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true, "x": 127.2, "y": 135.0}, {"label": "29 Jun 23:59", "short_label": "29 Jun", "collected_at": "2026-06-29T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 7, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true, "x": 148.5, "y": 135.0}, {"label": "03 Jul 23:59", "short_label": "03 Jul", "collected_at": "2026-07-03T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 8, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true, "x": 169.8, "y": 135.0}, {"label": "06 Jul 23:59", "short_label": "06 Jul", "collected_at": "2026-07-06T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 9, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true, "x": 191.1, "y": 135.0}, {"label": "10 Jul 23:59", "short_label": "10 Jul", "collected_at": "2026-07-10T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 10, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true, "x": 212.4, "y": 135.0}, {"label": "11 Jul 23:59", "short_label": "11 Jul", "collected_at": "2026-07-11T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 11, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true, "x": 233.7, "y": 135.0}, {"label": "15 Jul 23:59", "short_label": "15 Jul", "collected_at": "2026-07-15T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 12, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true, "x": 255.0, "y": 135.0}, {"label": "22 Jul 23:59", "short_label": "22 Jul", "collected_at": "2026-07-22T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 2, "tone": "neutral", "height": 4, "articles": 14, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v11", "reconstructed": true, "x": 276.3, "y": 135.0}, {"label": "23 Jul 23:59", "short_label": "23 Jul", "collected_at": "2026-07-23T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 26, "article_change": 1, "tone": "neutral", "height": 4, "articles": 15, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 297.6, "y": 135.0}, {"label": "24 Jul 23:59", "short_label": "24 Jul", "collected_at": "2026-07-24T23:59:59.999999+00:00", "score": 48, "delta": -2, "score_change": -2, "score_change_display": "-2", "confidence_change": 3, "article_change": 1, "tone": "neutral", "height": 4, "articles": 16, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 318.9, "y": 138.6}, {"label": "25 Jul 23:59", "short_label": "25 Jul", "collected_at": "2026-07-25T23:59:59.999999+00:00", "score": 48, "delta": -2, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": 0, "tone": "neutral", "height": 4, "articles": 16, "confidence": 27, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 340.2, "y": 138.6}, {"label": "27 Jul 23:59", "short_label": "27 Jul", "collected_at": "2026-07-27T23:59:59.999999+00:00", "score": 47, "delta": -3, "score_change": -1, "score_change_display": "-1", "confidence_change": 3, "article_change": 0, "tone": "neutral", "height": 6, "articles": 16, "confidence": 30, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 361.5, "y": 140.5}, {"label": "28 Jul 23:59", "short_label": "28 Jul", "collected_at": "2026-07-28T23:59:59.999999+00:00", "score": 47, "delta": -3, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": 2, "tone": "neutral", "height": 6, "articles": 18, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 382.8, "y": 140.5}, {"label": "29 Jul 23:59", "short_label": "29 Jul", "collected_at": "2026-07-29T23:59:59.999999+00:00", "score": 47, "delta": -3, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": 0, "tone": "neutral", "height": 6, "articles": 18, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 404.1, "y": 140.5}, {"label": "30 Jul 23:59", "short_label": "30 Jul", "collected_at": "2026-07-30T23:59:59.999999+00:00", "score": 47, "delta": -3, "score_change": 0, "score_change_display": "+0", "confidence_change": 5, "article_change": 1, "tone": "neutral", "height": 6, "articles": 19, "confidence": 31, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 425.4, "y": 140.5}, {"label": "01 Aug 23:59", "short_label": "01 Aug", "collected_at": "2026-08-01T23:59:59.999999+00:00", "score": 47, "delta": -3, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 2, "tone": "neutral", "height": 6, "articles": 21, "confidence": 31, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 446.7, "y": 140.5}, {"label": "02 Aug 23:59", "short_label": "02 Aug", "collected_at": "2026-08-02T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": 2, "score_change_display": "+2", "confidence_change": 2, "article_change": 0, "tone": "neutral", "height": 4, "articles": 21, "confidence": 33, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 468.0, "y": 136.8}, {"label": "04 Aug 23:59", "short_label": "04 Aug", "collected_at": "2026-08-04T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": 0, "score_change_display": "+0", "confidence_change": -4, "article_change": 1, "tone": "neutral", "height": 4, "articles": 22, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 489.3, "y": 136.8}, {"label": "06 Aug 23:59", "short_label": "06 Aug", "collected_at": "2026-08-06T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": 0, "score_change_display": "+0", "confidence_change": -3, "article_change": 1, "tone": "neutral", "height": 4, "articles": 23, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 510.7, "y": 136.8}, {"label": "08 Aug 23:59", "short_label": "08 Aug", "collected_at": "2026-08-08T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 3, "score_change_display": "+3", "confidence_change": 3, "article_change": 1, "tone": "neutral", "height": 4, "articles": 24, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 532.0, "y": 131.4}, {"label": "10 Aug 23:59", "short_label": "10 Aug", "collected_at": "2026-08-10T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 0, "score_change_display": "+0", "confidence_change": 1, "article_change": 0, "tone": "neutral", "height": 4, "articles": 24, "confidence": 30, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 553.3, "y": 131.4}, {"label": "13 Aug 23:59", "short_label": "13 Aug", "collected_at": "2026-08-13T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 0, "score_change_display": "+0", "confidence_change": -5, "article_change": 2, "tone": "neutral", "height": 4, "articles": 26, "confidence": 25, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 574.6, "y": 131.4}, {"label": "17 Aug 23:59", "short_label": "17 Aug", "collected_at": "2026-08-17T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": -2, "score_change_display": "-2", "confidence_change": 1, "article_change": 0, "tone": "neutral", "height": 4, "articles": 26, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 595.9, "y": 135.0}, {"label": "25 Aug 23:59", "short_label": "25 Aug", "collected_at": "2026-08-25T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": -8, "article_change": -6, "tone": "neutral", "height": 4, "articles": 20, "confidence": 18, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 617.2, "y": 135.0}, {"label": "31 Aug 23:59", "short_label": "31 Aug", "collected_at": "2026-08-31T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": -8, "tone": "neutral", "height": 4, "articles": 12, "confidence": 16, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 638.5, "y": 135.0}, {"label": "01 Sep 23:59", "short_label": "01 Sep", "collected_at": "2026-09-01T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 1, "score_change_display": "+1", "confidence_change": 12, "article_change": 1, "tone": "neutral", "height": 4, "articles": 13, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 659.8, "y": 133.2}, {"label": "02 Sep 23:59", "short_label": "02 Sep", "collected_at": "2026-09-02T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 14, "confidence": 27, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 681.1, "y": 133.2}, {"label": "04 Sep 23:59", "short_label": "04 Sep", "collected_at": "2026-09-04T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 1, "score_change_display": "+1", "confidence_change": 5, "article_change": 0, "tone": "neutral", "height": 4, "articles": 14, "confidence": 32, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 702.4, "y": 131.4}, {"label": "09 Sep 23:59", "short_label": "09 Sep", "collected_at": "2026-09-09T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": -1, "score_change_display": "-1", "confidence_change": -4, "article_change": -4, "tone": "neutral", "height": 4, "articles": 10, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 723.7, "y": 133.2}, {"label": "11 Sep 23:59", "short_label": "11 Sep", "collected_at": "2026-09-11T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": -4, "article_change": 1, "tone": "neutral", "height": 4, "articles": 11, "confidence": 24, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 745.0, "y": 133.2}, {"label": "14 Sep 23:59", "short_label": "14 Sep", "collected_at": "2026-09-14T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": -1, "tone": "neutral", "height": 4, "articles": 10, "confidence": 22, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 766.3, "y": 133.2}, {"label": "20 Sep 23:59", "short_label": "20 Sep", "collected_at": "2026-09-20T23:59:59.999999+00:00", "score": 48, "delta": -2, "score_change": -3, "score_change_display": "-3", "confidence_change": 7, "article_change": 0, "tone": "neutral", "height": 4, "articles": 10, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 787.6, "y": 138.6}, {"label": "25 Sep 23:59", "short_label": "25 Sep", "collected_at": "2026-09-25T23:59:59.999999+00:00", "score": 47, "delta": -3, "score_change": -1, "score_change_display": "-1", "confidence_change": 1, "article_change": 1, "tone": "neutral", "height": 6, "articles": 11, "confidence": 30, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 808.9, "y": 140.5}, {"label": "28 Sep 23:59", "short_label": "28 Sep", "collected_at": "2026-09-28T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": 2, "score_change_display": "+2", "confidence_change": 1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 12, "confidence": 31, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 830.2, "y": 136.8}, {"label": "29 Sep 23:59", "short_label": "29 Sep", "collected_at": "2026-09-29T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": 2, "tone": "neutral", "height": 4, "articles": 14, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 851.5, "y": 136.8}, {"label": "30 Sep 23:59", "short_label": "30 Sep", "collected_at": "2026-09-30T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": 0, "tone": "neutral", "height": 4, "articles": 14, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 872.8, "y": 136.8}, {"label": "02 Oct 23:59", "short_label": "02 Oct", "collected_at": "2026-10-02T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": 0, "score_change_display": "+0", "confidence_change": 1, "article_change": 0, "tone": "neutral", "height": 4, "articles": 14, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 894.1, "y": 136.8}, {"label": "03 Oct 23:59", "short_label": "03 Oct", "collected_at": "2026-10-03T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": 0, "score_change_display": "+0", "confidence_change": -3, "article_change": 2, "tone": "neutral", "height": 4, "articles": 16, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 915.4, "y": 136.8}, {"label": "05 Oct 23:59", "short_label": "05 Oct", "collected_at": "2026-10-05T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": 0, "score_change_display": "+0", "confidence_change": -3, "article_change": 0, "tone": "neutral", "height": 4, "articles": 16, "confidence": 23, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 936.7, "y": 136.8}, {"label": "11 Oct 20:16", "short_label": "11 Oct", "collected_at": "2026-10-11T20:16:07.913981+00:00", "score": 50, "delta": 0, "score_change": 1, "score_change_display": "+1", "confidence_change": -4, "article_change": -2, "tone": "neutral", "height": 4, "articles": 14, "confidence": 19, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true, "x": 958.0, "y": 135.0}], "chart_points": "42.0,135.0 63.3,135.0 84.6,135.0 105.9,135.0 127.2,135.0 148.5,135.0 169.8,135.0 191.1,135.0 212.4,135.0 233.7,135.0 255.0,135.0 276.3,135.0 297.6,135.0 318.9,138.6 340.2,138.6 361.5,140.5 382.8,140.5 404.1,140.5 425.4,140.5 446.7,140.5 468.0,136.8 489.3,136.8 510.7,136.8 532.0,131.4 553.3,131.4 574.6,131.4 595.9,135.0 617.2,135.0 638.5,135.0 659.8,133.2 681.1,133.2 702.4,131.4 723.7,133.2 745.0,133.2 766.3,133.2 787.6,138.6 808.9,140.5 830.2,136.8 851.5,136.8 872.8,136.8 894.1,136.8 915.4,136.8 936.7,136.8 958.0,135.0", "changes": [{"label": "11 Oct 20:16", "short_label": "11 Oct", "collected_at": "2026-10-11T20:16:07.913981+00:00", "score": 50, "delta": 0, "score_change": 1, "score_change_display": "+1", "confidence_change": -4, "article_change": -2, "tone": "neutral", "height": 4, "articles": 14, "confidence": 19, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "05 Oct 23:59", "short_label": "05 Oct", "collected_at": "2026-10-05T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": 0, "score_change_display": "+0", "confidence_change": -3, "article_change": 0, "tone": "neutral", "height": 4, "articles": 16, "confidence": 23, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "03 Oct 23:59", "short_label": "03 Oct", "collected_at": "2026-10-03T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": 0, "score_change_display": "+0", "confidence_change": -3, "article_change": 2, "tone": "neutral", "height": 4, "articles": 16, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "02 Oct 23:59", "short_label": "02 Oct", "collected_at": "2026-10-02T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": 0, "score_change_display": "+0", "confidence_change": 1, "article_change": 0, "tone": "neutral", "height": 4, "articles": 14, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "30 Sep 23:59", "short_label": "30 Sep", "collected_at": "2026-09-30T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": 0, "tone": "neutral", "height": 4, "articles": 14, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "29 Sep 23:59", "short_label": "29 Sep", "collected_at": "2026-09-29T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": 2, "tone": "neutral", "height": 4, "articles": 14, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "28 Sep 23:59", "short_label": "28 Sep", "collected_at": "2026-09-28T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": 2, "score_change_display": "+2", "confidence_change": 1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 12, "confidence": 31, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}, {"label": "25 Sep 23:59", "short_label": "25 Sep", "collected_at": "2026-09-25T23:59:59.999999+00:00", "score": 47, "delta": -3, "score_change": -1, "score_change_display": "-1", "confidence_change": 1, "article_change": 1, "tone": "neutral", "height": 6, "articles": 11, "confidence": 30, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v11", "reconstructed": true}]}, "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}